Mylan Laboratories Limited Rosuvastatin Export Data — India (DGFT 2022–2026)

Name: Mylan Laboratories Limited Rosuvastatin Export Records India — #10 Exporter, 621 Shipments, $13.0M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Rosuvastatin

India Pharmaceutical Trade Intelligence

$463.3M427 Suppliers143 CountriesHS 30049099

ExportsIndia → UNITED STATES42.3%India → AUSTRALIA17.2%

ImportsPUERTO RICO → India$1015.1B CHINA → India$980.1K

#1 Supplier: STRIDES PHARMA

Mylan Laboratories Limited — Rosuvastatin Exporter #10 | $13.0M Trade Value | TransData Nexus | TransData Nexus

Mylan Laboratories Limited — Rosuvastatin Exporter Profile

Indian Pharmaceutical Exporter · #10 for Rosuvastatin · $13.0M export value · DGFT Verified

Mylan Laboratories Limited is the #10 Indian exporter of Rosuvastatin with $13.0M in export value and 621 verified shipments. Mylan Laboratories Limited holds a 2.8% market share in Rosuvastatin exports across 9 countries. The company exports 91 pharmaceutical products worth $634.8M across 26 therapeutic categories.

Mylan Laboratories Limited — Rosuvastatin Export Profile: Buyers & Destinations

Mylan Laboratories Limited Rosuvastatin export treemap — buyers and destination countries | TransData Nexus

Where Does Mylan Laboratories Limited Export Rosuvastatin?

Country	Value	Shipments	Share
FRANCE	$5.3M	193	46.1%
NETHERLANDS	$2.1M	218	18.5%
ITALY	$1.6M	67	13.6%
NEW ZEALAND	$1.3M	46	11.7%
BELGIUM

Who Are the Top Buyers of Rosuvastatin from Mylan Laboratories Limited?

Buyer	Country	Value	Orders
CSP VIATRIS SANTE AT CSP- LAB,	FRANCE	$1.1M	51
MYLAN IRELAND C/O ALLOGA RDC,	NETHERLANDS	$759.6K	79
CSP MYLAN SAS AT CSP LABO 274	FRANCE	$703.7K	20
CSP VIATRIS SANTE AT CSP- LAB	FRANCE	$631.1K	17
CSP VIATRIS SANTE AT CSP LAB	FRANCE	$613.8K	17
VIATRIS LIMITED	NEW ZEALAND	$533.7K	20
CSP VIATRIS SANTE AT CSP-LAB	FRANCE	$443.2K	12
VIATRIS LIMITED,	NEW ZEALAND	$435.9K	13
VIATRIS ITALIA S.R.L.	ITALY	$418.5K	21
M/S. CSP MYLAN SAS AT CSP LABO 274	FRANCE	$386.0K	13

Mylan Laboratories Limited supplies Rosuvastatin to 79 buyers globally. The largest buyer is CSP VIATRIS SANTE AT CSP- LAB, (FRANCE), followed by MYLAN IRELAND C/O ALLOGA RDC, (NETHERLANDS) and CSP MYLAN SAS AT CSP LABO 274 (FRANCE). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Rosuvastatin Formulations Does Mylan Laboratories Limited Export?

Product Description / Formulation	Value	Shipments
ROSUVASTATINE MYLAN 5 MG TAB 90 BL PACKS	$279.7K	8
HARMLESS MEDICINES, ROSUVASTATINE MYLAN	$249.3K	18
HARMLESS MEDICINES, ROSUVASTATINA MYLAN	$218.7K	7
ROSUVASTATINE MYLAN 5 MG 30BL TAB PACKS	$218.2K	6
ROSUVASTATINE MYLAN 5 MG TAB 90BL PACKS	$205.7K	5
ROSUVASTATINE MYLAN 5 MG 30 BL TAB PACKS	$184.4K	5
ROSUVASTATINE MYLAN 10 MG 30 BL TAB PACK	$157.7K	5
ROSUVASTATINE MYLAN 20 MG 90 BL TAB PACK	$150.0K	3
ROSUVASTATINE MYLAN 20 MG 30 BL TAB PACK	$122.5K	3
HARMLESS MEDICINES, ROSUVASTATIN VIATRISTAB 40MG 30 BOT NZ (59026 PACKS)	$121.1K	3

Mylan Laboratories Limited exports 410 distinct Rosuvastatin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is ROSUVASTATINE MYLAN 5 MG TAB 90 BL PACKS with 8 shipments worth $279.7K.

How Does Mylan Laboratories Limited Compare to Nearest Rosuvastatin Exporters?

Exporters ranked immediately above and below #10 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
1	STRIDES PHARMA SCIENCE LIMITED	$21.0M	420	3	$50.0K
8	MEDREICH LIMITED	$16.7M	684	13	$24.5K
10	MYLAN LABORATORIES LIMITED ★	$13.0M	621	9	$21.0K
11	HETERO LABS LIMITED	$11.7M	239	10	$48.9K
9	AUROBINDO PHARMA LIMITED	$10.7M	213	6	$50.0K

Mylan Laboratories Limited ranks #10 among 427 Indian Rosuvastatin exporters. Average shipment value of $21.0K compared to the market average of $751.9K. The closest competitors by value are STRIDES PHARMA SCIENCE LIMITED and MEDREICH LIMITED.

Which Indian Ports Ship Rosuvastatin Exports?

Port	Shipments	% Share
NHAVA SHEVA SEA (INNSA1)	1,090	8.1%
SAHAR AIR	921	6.8%
SAHAR AIR CARGO ACC (INBOM4)	909	6.7%
HYDERABAD ICD (INSNF6)	878	6.5%
DELHI AIR CARGO ACC (INDEL4)	769	5.7%
JNPT/ NHAVA SHEVA SEA	699	5.2%
DELHI AIR	635	4.7%
HYDERABAD ICD	550	4.1%

Geopolitical & Trade Policy Impact on Mylan Laboratories Limited's Rosuvastatin Exports

Mylan's export operations are influenced by a complex geopolitical landscape. The Israel-Iran tensions have led to disruptions in Red Sea shipping routes, resulting in increased freight costs and extended transit times. Major shipping lines have implemented 'Emergency Risk Surcharges' ranging from $250 to $500 per TEU, directly impacting the cost structure for Indian pharmaceutical exporters like Mylan. Additionally, diversions around the Cape of Good Hope have further elongated delivery schedules, posing challenges to time-sensitive pharmaceutical shipments.

In the United States, the imposition of tariffs on pharmaceutical imports has prompted Indian companies to reassess their market strategies. While generics have largely remained exempt, the potential for future tariff expansions necessitates vigilance. Mylan, along with other Indian exporters, is exploring market diversification to mitigate reliance on the U.S. market. The recent India-European Union Free Trade Agreement (FTA), signed in January 2026, offers a strategic avenue for expansion. The FTA eliminates tariffs on approximately 97% of EU tariff lines, including pharmaceuticals, thereby enhancing market access for Indian exporters. This agreement is expected to significantly boost India's pharmaceutical exports to Europe, providing a counterbalance to uncertainties in the U.S. market.

Mylan Laboratories Limited — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards remains paramount for Mylan. The FDA's warning letter and import alert in December 2024 concerning the Indore facility underscore the critical importance of stringent quality control measures. The cited violations, including subpar quality control and improper management of manufacturing defects, have necessitated comprehensive corrective actions. Mylan's proactive response aims to restore compliance and reinforce its commitment to quality assurance.

The evolving regulatory environment, particularly in the European Union, further emphasizes the need for adherence to Good Manufacturing Practices (GMP). The EU's Falsified Medicines Directive mandates rigorous compliance to ensure product integrity and patient safety. For Mylan, aligning with these standards is essential to maintain and expand its foothold in the European market.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Rosuvastatin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Mylan Laboratories Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 621 individual customs records matching Mylan Laboratories Limited exporting Rosuvastatin, covering 410 formulations to 9 countries via 79 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 143+ countries, 1,314+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Rosuvastatin

Rosuvastatin

Mylan Laboratories Limited — Rosuvastatin Exporter Profile

Mylan Laboratories Limited — Rosuvastatin Export Profile: Buyers & Destinations

Where Does Mylan Laboratories Limited Export Rosuvastatin?

Who Are the Top Buyers of Rosuvastatin from Mylan Laboratories Limited?

What Is India's Total Rosuvastatin Export Value and How Much Does Mylan Laboratories Limited Contribute?

What Is the Average Shipment Value for Mylan Laboratories Limited's Rosuvastatin Exports?

How Does Mylan Laboratories Limited Compare to Other Indian Rosuvastatin Exporters?

What Rosuvastatin Formulations Does Mylan Laboratories Limited Export?

How Does Mylan Laboratories Limited Compare to Nearest Rosuvastatin Exporters?

Which Indian Ports Ship Rosuvastatin Exports?

What Other Cardiovascular Products Does Mylan Laboratories Limited Export?

Geopolitical & Trade Policy Impact on Mylan Laboratories Limited's Rosuvastatin Exports

Mylan Laboratories Limited — Regulatory Compliance & Quality Standards

About Mylan Laboratories Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Rosuvastatin Export Data from Mylan Laboratories Limited

Rosuvastatin Stats

Company Overview

Top Products by Mylan Laboratories Limited

Related Analysis

Need Detailed Export Data?

Data Source